Literature DB >> 6824843

Influence of background and absorption correction on nuclear quantification of left ventricular end-diastolic volume.

M Seiderer, I Bohn, U Buell, E Kleinhans, B E Strauer.   

Abstract

Left ventricular (LV) end-diastolic volume (EDV) was determined in millilitres by equilibrium radionuclide ventriculography (MUGA) in 38 patients and in 15 normal individuals by applying corrections for background (BC), LV blood self-absorption and for absorption by the thoracic and LV walls. Volume calibration was performed by measuring a syringe containing the patient's venous blood with the gamma camera. Single plane cineventriculography (CVG) served as the reference method. Without absorption correction, LV volume values were underestimated by a factor of 3.6 on the average. Several background models (uniform, parabolic, no background) were investigated. Without BC, EDV was overestimated, and with uniform BC, EDV was underestimated. EDV calculated using a parabolic BC with a correction for absorption yielded the best correlation (r = 0.96) with volumes (VOL) obtained by CVG (VOLMUGA [ml] = -6.83 + 1.060 X VOLCVG).

Entities:  

Mesh:

Year:  1983        PMID: 6824843     DOI: 10.1259/0007-1285-56-663-183

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  3 in total

1.  Combined evaluation of first pass radionuclide angiography and equilibrium radionuclide ventriculography in the diagnosis of coronary artery disease. II. Results during exercise.

Authors:  P Knesewitsch; S Fritsch; E Kleinhans; U Büll
Journal:  Eur J Nucl Med       Date:  1987

2.  Combined evaluation of first-pass radionuclide angiography and equilibrium radionuclide ventriculography in the diagnosis of coronary artery disease. I. Results at rest.

Authors:  P Knesewitsch; E Kleinhans; U Buell
Journal:  Eur J Nucl Med       Date:  1986

Review 3.  Quantitative radionuclide angiocardiography.

Authors:  J Grégoire; J A Parker; B L Holman
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.